Infrared spectrum of a DNA–RNA hybrid
✍ Scribed by Shigesada Higuchi; Masamichi Tsuboi; Yoichi Iitaka
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1969
- Tongue
- English
- Weight
- 456 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
✦ Synopsis
The infrared absorption spectrum in the 4000-400 cm-1 region of an oriented film of a DNA-RNA hybrid in its undeuterated and deuterated states was observed with the polarized radiation. Most of the stronger bands found in the double-helical DNA's and doublehelical RNA's are identified in the spectrum of the hybrid. The absorption band at 1225 cm-1 shows a perpendicular dichroism and that at 1085 cm-1 shows almost no dichroism. These facts indicate that the orientation of the P /' group with respect to the helix axis in the hybrid structure is not entirely the same as that in the double-helical Na DNA at 75% RH., although the x-ray diffraction pattern of the hybrid is quite similar to that of the DNA A form. The POZorientation is not the same as that in the double-helical RNA either. The observed dichroism is explained, however, by considering that the PO2group in the RNA moiety takes nearly the same orientation as that in the double-helical RNA, and the POzgroup in the DNA moiety takes nearly the same as that in the double-helical DNA.
📜 SIMILAR VOLUMES
A closed-circular DNA duplex, especially a plasmid, for example, is known to have a n interwound right-handed (negative sense by definition) superhelical structure when it is isolated "intact" from a living cell.' Such a superhelical structure is considered to involve appreciable alterations in DNA
## Abstract Using circular dichroism spectroscopy, gel electrophoresis, and ultraviolet absorption spectroscopy, we have studied quadruplex folding of RNA/DNA analogs of the __Oxytricha__ telomere fragment, G~4~T~4~G~4~, which forms the well‐known basket‐type, antiparallel quadruplex. We have subst
obtained his MD degree from the University of Minnesota in 1964. In 1966 he moved to Bethesda, for what eventually became 32 years at the National Institutes of Health where he developed his career long interest in the investigation and treatment of patients with primary immunode®ciency disease. In